Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative

Mikkael A. Sekeres, Stephanie A. Stowell, Carolyn Berry, William M. Mencia, Ja Neen N Dancy

Research output: Contribution to journalArticle

Abstract

Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate classification requires careful consideration of pathologic features and cytogenetics, and treatment options vary based on disease severity. A performance improvement (PI) continuing medical education initiative was developed to strengthen physician practices and improve the quality of MDS patient care. Physician participants demonstrated significant gains in the diagnosis and classification of MDS and in the documentation of erythropoietin levels. Improvements related to patient communication and disease education were also observed and support the overall efficacy and value of PI in MDS patient care.

Original languageEnglish (US)
Pages (from-to)422-426
Number of pages5
JournalLeukemia Research
Volume37
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Myelodysplastic Syndromes
Patient Care
Physicians
Continuing Medical Education
Therapeutics
Erythropoietin
Cytogenetics
Documentation
Communication
Education

Keywords

  • Continuing medical education
  • Myelodysplastic syndromes
  • Performance improvement
  • Quality patient care

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative. / Sekeres, Mikkael A.; Stowell, Stephanie A.; Berry, Carolyn; Mencia, William M.; Dancy, Ja Neen N.

In: Leukemia Research, Vol. 37, No. 4, 04.2013, p. 422-426.

Research output: Contribution to journalArticle

Sekeres, Mikkael A. ; Stowell, Stephanie A. ; Berry, Carolyn ; Mencia, William M. ; Dancy, Ja Neen N. / Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative. In: Leukemia Research. 2013 ; Vol. 37, No. 4. pp. 422-426.
@article{f41a7941f0c146519b08910c75f149b6,
title = "Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative",
abstract = "Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate classification requires careful consideration of pathologic features and cytogenetics, and treatment options vary based on disease severity. A performance improvement (PI) continuing medical education initiative was developed to strengthen physician practices and improve the quality of MDS patient care. Physician participants demonstrated significant gains in the diagnosis and classification of MDS and in the documentation of erythropoietin levels. Improvements related to patient communication and disease education were also observed and support the overall efficacy and value of PI in MDS patient care.",
keywords = "Continuing medical education, Myelodysplastic syndromes, Performance improvement, Quality patient care",
author = "Sekeres, {Mikkael A.} and Stowell, {Stephanie A.} and Carolyn Berry and Mencia, {William M.} and Dancy, {Ja Neen N}",
year = "2013",
month = "4",
doi = "10.1016/j.leukres.2012.12.009",
language = "English (US)",
volume = "37",
pages = "422--426",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative

AU - Sekeres, Mikkael A.

AU - Stowell, Stephanie A.

AU - Berry, Carolyn

AU - Mencia, William M.

AU - Dancy, Ja Neen N

PY - 2013/4

Y1 - 2013/4

N2 - Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate classification requires careful consideration of pathologic features and cytogenetics, and treatment options vary based on disease severity. A performance improvement (PI) continuing medical education initiative was developed to strengthen physician practices and improve the quality of MDS patient care. Physician participants demonstrated significant gains in the diagnosis and classification of MDS and in the documentation of erythropoietin levels. Improvements related to patient communication and disease education were also observed and support the overall efficacy and value of PI in MDS patient care.

AB - Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate classification requires careful consideration of pathologic features and cytogenetics, and treatment options vary based on disease severity. A performance improvement (PI) continuing medical education initiative was developed to strengthen physician practices and improve the quality of MDS patient care. Physician participants demonstrated significant gains in the diagnosis and classification of MDS and in the documentation of erythropoietin levels. Improvements related to patient communication and disease education were also observed and support the overall efficacy and value of PI in MDS patient care.

KW - Continuing medical education

KW - Myelodysplastic syndromes

KW - Performance improvement

KW - Quality patient care

UR - http://www.scopus.com/inward/record.url?scp=84875373972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875373972&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2012.12.009

DO - 10.1016/j.leukres.2012.12.009

M3 - Article

C2 - 23306108

AN - SCOPUS:84875373972

VL - 37

SP - 422

EP - 426

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 4

ER -